Literature DB >> 6740835

Significance of plasma tissue polypeptide antigen determination for diagnosis and follow-up of urothelial bladder cancer.

H D Adolphs, P Oehr.   

Abstract

Plasma concentrations of tissue polypeptide antigen (TPA) were determined in 104 patients with all stages and grades of urinary bladder cancer. Patients with evidence of bacterial or virus infections were excluded. In addition, follow-up controls after treatment were performed. At a rate of 5% false positive values, the diagnostic sensitivity for the tumour stage pTis/pT1 was 63% and for the stages pT2-4 it was 76%. Patients with proved lymph node or distant metastases showed elevated values in 100% of cases. A positive correlation was found between the 3 grades of malignancy and the TPA concentrations. Except for the tumour diagnosis, TPA is a valuable parameter for follow-up controls. Our results show a very good correlation of the plasma TPA concentration with tumour progression as well as with stabilisation and regression after treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6740835     DOI: 10.1007/BF00257178

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  3 in total

1.  A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms.

Authors:  C J Menendez-Botet; H F Oettgen; C M Pinsky; M K Schwartz
Journal:  Clin Chem       Date:  1978-06       Impact factor: 8.327

2.  Frequent elevation of tissue polypeptide antigen in the sera of workers exposed to bladder carcinogens.

Authors:  S Kumar; P Wilson; P Brenchley; G Taylor; B Björklund; G Eklund
Journal:  Int J Cancer       Date:  1978-11-15       Impact factor: 7.396

3.  Immuno-histochemical localization of tissue polypeptide antigen (TPA) and carcino-embryonic antigen (CEA) in breast cancer. A comparative study.

Authors:  V Björklund; B Björklund; C Wittekind; S von Kleist
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1982-11
  3 in total
  5 in total

1.  Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma.

Authors:  B E Carbin; P Ekman; P Eneroth; B Nilsson
Journal:  Urol Res       Date:  1989

2.  Tissue polypeptide antigen (TPA), some cytokeratins and epithelial membrane antigen (EMA) in normal, inflamed and malignant urothelium.

Authors:  B E Carbin; V P Collins; P Ekman
Journal:  Urol Res       Date:  1987

Review 3.  History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.

Authors:  Haruhiko Nakamura; Toshihide Nishimura
Journal:  Surg Today       Date:  2017-02-22       Impact factor: 2.549

4.  Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract.

Authors:  A van der Gaast; W J Kirkels; B G Blijenberg; T A Splinter
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

5.  Simultaneous determination of six tumor markers in patients with prostatic carcinoma and bladder tumors.

Authors:  B Schwemmer; W Schütz; R M Kuntz; A Lehmer
Journal:  Urol Res       Date:  1985
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.